Alba Font‐Tello

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu et al. · Nature Genetics · 2020 · 289 citations · Full text

Medicine, Molecular Biology, Oncology +16

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Shengqing Gu, Wubing Zhang, Xiaoqing Wang et al. · Cancer Discovery · 2021 · 282 citations · Full text

Life Sciences, Immunology, Oncology +16

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge et al. · Molecular Cell · 2020 · 207 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink et al. · Nature Medicine · 2019 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +12

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Paloma Cejas, Yingtian Xie, Alba Font‐Tello et al. · Nature Communications · 2021 · 161 citations · Full text

Medicine, Molecular Biology, Oncology +17